Foster City, CA, April 18, 2007 – Entelos, Inc. (LSE: ENTL), a leading life sciences company building predictive computer models of human physiology and “virtual patients” for drug discovery and development, today announces its preliminary results for the twelve months ended 31 December 2006.
